Insider · CIK 0001402439

ARCH Venture Fund VII, L.P.

Reports to the SEC for 12 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001402439

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-12-22	MASS908 Devices Inc.C Conversion	10% Owner	CConversion	+5.43M sh	—	—	5,425,045
2020-12-22	MASS908 Devices Inc.P Purchase	10% Owner	PPurchase	+300K sh	$20.00	+$6M	5,725,045
2020-12-22	MASS908 Devices Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−2.93M sh	—	—	0
2020-12-22	MASS908 Devices Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−981K sh	—	—	0
2020-12-22	MASS908 Devices Inc. · Series C Preferred StockC Conversion	10% Owner	CConversion	−670K sh	—	—	0
2020-12-22	MASS908 Devices Inc. · Series D Preferred StockC Conversion	10% Owner	CConversion	−666K sh	—	—	0
2020-12-22	MASS908 Devices Inc. · Series E Preferred StockC Conversion	10% Owner	CConversion	−181K sh	—	—	0
2019-07-17	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−34.5K sh	$7.70	−$266K	4,242,051
2019-07-16	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−25.8K sh	$7.81	−$201K	4,276,572
2019-07-15	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,700 sh	$8.27	−$22.3K	4,302,051
2019-03-14	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−43K sh	$8.15	−$350K	4,305,051
2019-03-13	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−81.6K sh	$7.89	−$643K	4,350,871
2019-03-13	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−2,820 sh	$8.20	−$23.1K	4,348,051
2019-03-12	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−40.1K sh	$7.37	−$295K	4,432,462
2019-03-11	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−44.9K sh	$6.49	−$291K	4,472,554
2019-03-08	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−84.5K sh	$6.93	−$585K	4,517,432
2019-03-07	Syros Pharmaceuticals, Inc.S Sale	10% Owner	SSale	−35.2K sh	$6.87	−$242K	4,601,928
2016-07-06	Syros Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+2M sh	—	—	3,813,332
2016-07-06	Syros Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+424K sh	—	—	4,237,137
2016-07-06	Syros Pharmaceuticals, Inc.P Purchase	10% Owner	PPurchase	+400K sh	$12.50	+$5M	4,637,137
2016-07-06	Syros Pharmaceuticals, Inc.Series A-1 Preferred StockC Conversion	10% Owner	CConversion	−1M sh	—	—	0
2016-07-06	Syros Pharmaceuticals, Inc.Series A-2 Preferred StockC Conversion	10% Owner	CConversion	−5M sh	—	—	0
2016-07-06	Syros Pharmaceuticals, Inc.Series A-3 Preferred StockC Conversion	10% Owner	CConversion	−7.5M sh	—	—	0
2016-07-06	Syros Pharmaceuticals, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−1.59M sh	—	—	0
2016-07-06	Syros Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+1.33M sh	—	—	1,813,332
2016-07-06	Syros Pharmaceuticals, Inc.C Conversion	10% Owner	CConversion	+267K sh	—	—	479,999
2016-03-15	Juno Therapeutics, Inc.J Other	10% Owner	JOther	−1M sh	—	—	10,552,390
2015-06-18	Sage Therapeutics, Inc.J Other	10% Owner	JOther	−1.06M sh	—	—	2,124,699
2015-02-19	AGIOAGIOS PHARMACEUTICALS, INC.J Other	10% Owner	JOther	−386K sh	—	—	3,088,590
2015-01-14	Sage Therapeutics, Inc.J Other	10% Owner	JOther	−1.06M sh	—	—	3,187,044
2014-12-23	Juno Therapeutics, Inc.C Conversion	10% Owner	CConversion	+6.25M sh	—	—	7,347,015
2014-12-23	Juno Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.75M sh	—	—	11,094,515
2014-12-23	Juno Therapeutics, Inc.C Conversion	10% Owner	CConversion	+458K sh	—	—	11,552,390
2014-12-23	Juno Therapeutics, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−6.25M sh	—	—	0
2014-12-23	Juno Therapeutics, Inc.Series A-2 Preferred StockC Conversion	10% Owner	CConversion	−3.75M sh	—	—	0
2014-12-23	Juno Therapeutics, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−458K sh	—	—	0
2014-07-23	Sage Therapeutics, Inc.Series C Preferred StockC Conversion	10% Owner	CConversion	−886K sh	—	—	0
2014-07-23	Sage Therapeutics, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−7.5M sh	—	—	0
2014-07-23	Sage Therapeutics, Inc.C Conversion	10% Owner	CConversion	+281K sh	—	—	4,249,389
2014-07-23	Sage Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.59M sh	—	—	1,587,301
2014-07-23	Sage Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.38M sh	—	—	3,968,252
2014-07-23	Sage Therapeutics, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−5M sh	—	—	0
2013-07-29	AGIOAGIOS PHARMACEUTICALS, INC.C Conversion	10% Owner	CConversion	+3.86M sh	—	—	3,860,738
2013-07-29	AGIOAGIOS PHARMACEUTICALS, INC. · Series A Convertible Preferred StockC Conversion	10% Owner	CConversion	−10M sh	—	—	0
2013-07-29	AGIOAGIOS PHARMACEUTICALS, INC. · Series C-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−617K sh	—	—	0
2013-06-24	bluebird bio, Inc.Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−14M sh	—	—	0
2013-06-24	bluebird bio, Inc.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−20M sh	—	—	0
2013-06-24	bluebird bio, Inc.C Conversion	10% Owner	CConversion	+1.79M sh	—	—	1,793,588
2013-05-14	Receptos, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−5.1M sh	—	—	0
2013-05-14	Receptos, Inc.C Conversion	10% Owner	CConversion	+680K sh	—	—	1,816,891

Recent filings

Accepted (ET)
Dec 224
ARCH Venture Fund VII, L.P.0001104659-20-138752
SEC(opens sec.gov)
Jul 174
ARCH Venture Fund VII, L.P.0001012975-19-000489
SEC(opens sec.gov)
Mar 144
ARCH Venture Fund VII, L.P.0001012975-19-000242
SEC(opens sec.gov)
Mar 114
NELSEN ROBERT0001012975-19-000225
SEC(opens sec.gov)
Jul 74
Syros Pharmaceuticals, Inc.0001104659-16-131409
SEC(opens sec.gov)

Companies

Address

8725 WEST HIGGINS ROAD, SUITE 290

CHICAGO, IL, 60631